Allergopharma GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1969-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.allergopharma.de
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
Phase 3
Completed
- Conditions
- Allergy
- Interventions
- Biological: placeboBiological: recombinant birch pollen allergen
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Target Recruit Count
- 255
- Registration Number
- NCT00554983
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid
Phase 3
Completed
- Conditions
- Rhinoconjunctivitis
- Interventions
- Biological: specific immunotherapy with Acaroid, subcutaneously, Up-titration till strength B 0.6 mL (6000 TU)
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Target Recruit Count
- 108
- Registration Number
- NCT00540631
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
Phase 3
Completed
- Conditions
- Birch Pollen Allergy
- First Posted Date
- 2006-03-31
- Last Posted Date
- 2013-03-11
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Registration Number
- NCT00309062
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
Phase 3
Completed
- Conditions
- Allergy
- First Posted Date
- 2006-03-31
- Last Posted Date
- 2013-03-11
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Registration Number
- NCT00309036
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV
Phase 2
Completed
- Conditions
- Birch Pollen Allergy
- First Posted Date
- 2005-12-19
- Last Posted Date
- 2013-03-04
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Registration Number
- NCT00266526
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
Phase 3
Completed
- Conditions
- Grass Pollen Allergy
- Interventions
- Other: ComparatorBiological: Grass pollen formulation
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2014-01-24
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Target Recruit Count
- 160
- Registration Number
- NCT00264459
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Efficacy and Safety of a Purified Standardised Wasp Venom Preparation
Phase 3
Completed
- Conditions
- Allergy
- First Posted Date
- 2005-12-12
- Last Posted Date
- 2013-03-11
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Registration Number
- NCT00263926
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Efficacy and Safety of a Purified Standardised Bee Venom Preparation
Phase 3
Completed
- Conditions
- Bee Venom Allergy
- First Posted Date
- 2005-12-12
- Last Posted Date
- 2013-03-04
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Registration Number
- NCT00263952
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens
Phase 3
Completed
- Conditions
- Pollen Allergy
- Interventions
- Other: PlaceboBiological: Birch pollen allergoid
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2014-07-03
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Target Recruit Count
- 253
- Registration Number
- NCT00263627
- Locations
- 🇩🇪
Allergopharma Joachim Ganzer KG, Reinbek, Germany
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis
Phase 3
Completed
- Conditions
- Grass Pollen Allergy
- Interventions
- Biological: Allergovit 6-grassesOther: Placebo
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2014-06-05
- Lead Sponsor
- Allergopharma GmbH & Co. KG
- Target Recruit Count
- 154
- Registration Number
- NCT00263601
- Locations
- 🇩🇪
Allergopharma GmbH & Co. KG, Reinbek, Germany
© Copyright 2025. All Rights Reserved by MedPath